Abiomed Inc.
22 Cherry Hill Drive
Danvers
MA
01923
United States
(978) 777-5410
Product(s):
Manufactures temporary cardiac assist devices
Ownership:
Public
Exchange:
NSDQ
symbol:
ABMD
2004 Revenue:
$25,739,000
2005 Revenue:
$38,216,000
2006 Revenue:
$43,670,000
2007 Revenue:
$50,649,000
2008 Revenue:
$58,941,000
Yahoo Quotes:
Chairman:
Michael R. Minogue
President:
Michael R. Minogue
CEO:
Michael R. Minogue Management:
William J. Bolt, SVP-global quality & service
Robert L. Bowen, VP, CFO
Andrew J. Greenfield, VP-healthcare solutions
Michael G. Howley, VP, GM- global sales and marketing
Robert T.V. Kung, SVP, Chief Scientific Officer
Stephen C. McEvoy, VP, general counsel
Thorsten Siess, CTO
David Weber, COO
Abiomed Inc.
Grant Total (2001-present):
$3,085,017.00 Product Submissions:
2003: An Artificial Myocardium for Pediatric Support, $99,547
2004: A Novel Polymeric Trileaflet Heart Valve Prosthesis, $99,870
2004: A Smart Polymer for Destination Cardiac Assist Devices, $99,837
2004: Fail-safe TET system for implanted life support devices, $81,573
Printer-friendly versionPermalink
Top News Stories
RECENT BLOG POSTS
- Testing Talk: ASTM F1717 spinal implant biaxial testing
- MedGadget's MedTech Monday: Signaling pathways foreshadow novel vascular therapies
- Weekly Wireless Roundup: iPhone medical app denied 510(k)
- FDA panel decision could boost Boston Scientific's CRM business
- What to expect when you’re expecting
- Chance-takers are accident-makers
- Weekly Wireless Roundup: Express Scripts inks pilot deal for GlowCap
- MedGadget's MedTech Monday: Croc mummy tomography
- Congress is incapable of a positive contribution to health care reimbursement
- Technically speaking, you don't always have to be technical
Navigation
